3,4-dehydro Cilostazol

3,4-dehydro Cilostazol
Item number Size Datasheet Manual SDS Delivery time Quantity Price
Cay35075-1 1 mg -

6 - 10 business days*

55.00€
Cay35075-5 5 mg -

6 - 10 business days*

216.00€
Cay35075-10 10 mg -

6 - 10 business days*

405.00€
Cay35075-25 25 mg -

6 - 10 business days*

941.00€
 
3,4-dehydro Cilostazol is an active metabolite of the PDE3A inhibitor cilostazol (Cay-15035). It... more
Product information "3,4-dehydro Cilostazol"
3,4-dehydro Cilostazol is an active metabolite of the PDE3A inhibitor cilostazol (Cay-15035). It is formed from cilostazol by the cytochrome P450 (CYP) isoforms CYP3A4 and CYP2C19.Formal Name: 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-2(1H)-quinolinone. CAS Number: 73963-62-9. Synonyms: OPC 13015. Molecular Formula: C20H25N5O2. Formula Weight: 367.4. Purity: >90%. Formulation: (Request formulation change), A solid. Solubility: DMSO: soluble. SMILES: O=C1C=CC2=C(N1)C=CC(OCCCCC3=NN=NN3C4CCCCC4)=C2. InChi Code: InChI=1S/C20H25N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h9-12,14,16H,1-8,13H2,(H,21,26). InChi Key: GHALECSGOJQOHW-UHFFFAOYSA-N.
Keywords: OPC 13015, 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-2(1H)-quinolinone
Supplier: Cayman Chemical
Supplier-Nr: 35075

Properties

Application: Cilostazol active metabolite
MW: 367.4 D
Formula: C20H25N5O2
Purity: >90%
Format: Solid

Database Information

CAS : 73963-62-9| Matching products
KEGG ID : K19021 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: -20°C)
Signal Word: Warning
GHS Hazard Pictograms:
H Phrases: H302, H361
P Phrases: P201, P202, P264, P270, P280, P301+310, P308+313, P330, P405, P501
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "3,4-dehydro Cilostazol"
Write a review
or to review a product.
Viewed